ICON plc Files 6-K with Vaccine Study Update

Ticker: ICLR · Form: 6-K · Filed: Aug 12, 2025 · CIK: 1060955

Icon PLC 6-K Filing Summary
FieldDetail
CompanyIcon PLC (ICLR)
Form Type6-K
Filed DateAug 12, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: update, clinical-trial, healthcare

TL;DR

ICON PLC dropped a 6-K update on a vaccine study - check Exhibit 99.1 for deets.

AI Summary

ICON plc filed a Form 6-K on August 12, 2025, to provide an update on a vaccine study. The filing includes Exhibit 99.1, which details this update.

Why It Matters

This filing provides stakeholders with crucial, timely information regarding ICON plc's involvement in vaccine research, potentially impacting investor sentiment and strategic decisions.

Risk Assessment

Risk Level: low — The filing is a routine update and does not appear to contain significant negative or positive news that would immediately alter the company's risk profile.

Key Players & Entities

FAQ

What specific vaccine study is ICON plc providing an update on?

The filing does not specify the exact vaccine study in the provided text, only that an update is being provided via Exhibit 99.1.

When was this Form 6-K filed?

This Form 6-K was filed on August 12, 2025.

What is the primary purpose of this 6-K filing?

The primary purpose is to report an update on a vaccine study provided by ICON plc.

Does ICON plc file annual reports under Form 20-F or 40-F?

ICON plc indicates it files annual reports under Form 20-F.

Where is ICON plc's principal executive office located?

ICON plc's principal executive office is located at South County Business Park, Leopardstown, Dublin 18, D18 X5R3, Ireland.

Filing Stats: 147 words · 1 min read · ~1 pages · Grade level 14 · Accepted 2025-08-12 16:17:30

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ICON plc s Nigel Clerkin Date August 12, 2025 Nigel Clerkin Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing